Key Quantitative Figures
- Amount Raised: ₹44.9999925 crore (4499.99 lakhs) through preferential issue of convertible warrants
- Funds Utilized: ₹38.3296 crore (3832.96 lakhs) as of reporting period
- Equity Shares Allotted: 38,46,153 equity shares of face value ₹5 each
- Issue Price per Warrant: ₹117
- Warrant Exercise Price: ₹87.75 per warrant (75% of issue price)
- Balance Amount Received: ₹33,74,99,925.75
Period Covered
Quarter ended September 30, 2026
Deviation Status
No deviation(s) or variation(s) in the utilization of proceeds raised through the preferential warrant issue. The company confirms full compliance with the originally disclosed utilization objectives.
Fund Utilization Purpose
Proceeds are being utilized to meet funding requirements for:
- Growth in the business of the Company
- General corporate purposes
- Working capital requirements
Governance and Approval
The nil statement of deviation(s) or variation(s) has been duly reviewed by the Audit Committee of the Company.
Additional Information
- Monitoring Agency: Not Applicable
- Shareholder Approval: Not Applicable (no deviation)
- Audit Committee Comments: Nil
- Auditor Comments: Nil